SARS-CoV-2 Omicron BA. 5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of …

…, M Wong, T Jean, CSP Foster, D Christ, AC Hoppe… - …, 2022 - thelancet.com
Background Genetically distinct viral variants of severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) have been recorded since January 2020. The introduction of global …

Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia

…, V Mathivanan, C Fichter, A Kindinger, AC Hoppe… - Nature …, 2022 - nature.com
Genetically distinct variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have emerged since the start of the COVID-19 pandemic. Over this period, we developed …

SARS-CoV-2 Omicron: evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern

…, S McAllery, V Mathivanan, C Fichter, AC Hoppe… - medrxiv, 2021 - medrxiv.org
Genetically distinct viral variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
have been recorded since January 2020. Over this time global vaccine programs …

Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti‐spike neutralizing IgG to SARS‐CoV‐2 variants, but preserved antigen …

…, V Klemm, CML Munier, AC Hoppe… - American Journal of …, 2023 - Wiley Online Library
Patients with indolent lymphoma undertaking recurrent or continuous B cell suppression are
at risk of severe COVID‐19. Patients and healthy controls (HC; N = 13) received two doses …

T follicular helper cell responses to SARS‐CoV‐2 vaccination among healthy and immunocompromised adults

MAA Boyd, A Carey Hoppe, AD Kelleher… - … and Cell Biology, 2023 - Wiley Online Library
The worldwide rollout of severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2)
vaccinations in the last 2 years has produced a multitude of studies investigating T‐cell …

[HTML][HTML] Rapid isolation and resolution immune evasion and viral fitness across contemporary SARS-CoV-2 variants

…, C Forster, H Sv, V Mathivanan, C Fitcher, AC Hoppe… - 2022 - europepmc.org
From late 2020 the world observed the rapid emergence of many distinct SARS-CoV-2 variants.
At the same time, pandemic responses coalesced into significant global vaccine roll-out …

Rapid isolation and resolution immune evasion and viral fitness across contemporary SARS-CoV-2 variants (preprint)

…, S van Hal, V Mathivanan, C Fitcher, AC Hoppe… - 2022 - pesquisa.bvsalud.org
From late 2020 the world observed the rapid emergence of many distinct SARS-CoV-2 variants.
At the same time, pandemic responses coalesced into significant global vaccine roll-out …

Development of Novel Transient Delivery Systems for Gene Therapy

C Fichter - 2023 - unsworks.unsw.edu.au
Alex Underwood, and Sam Ognenovska. Additionally, I would … , Annett Howe, and Alex
Carey Hoppe for always being … , Andrea Kindinger, Alexandra Carey Hoppe, Mee Ling Munier, …

Discontinuation versus continuation of hypertonic saline or dornase alfa in modulator treated people with cystic fibrosis (SIMPLIFY): results from two parallel …

…, J Taylor-Cousar, M Cross, J Hoppe… - The Lancet …, 2023 - thelancet.com
Background Reducing treatment burden is a priority for people with cystic fibrosis, whose
health has benefited from using new modulators that substantially increase CFTR protein …

Respiratory viruses of pandemic potential–SARS coronavirus-2 detection and prevention

G Walker - 2022 - unsworks.unsw.edu.au
Respiratory viruses remain a frequent cause of epidemic and pandemic spread causing
significant disease. The clinical phenotype varies significantly between individuals, and this …